News
CVS Health has shaken up its executive suite, appointing Brian Newman as CFO and Amy Compton-Phillips as Chief Medical Officer in a bid to bolster strategic direction and healthcare accessibility.
Key Takeaways The S&P 500 fell 1.6% on Tuesday, April 8, 2025, as investors braced for new tariffs to take effect.Albemarle shares tumbled after UBS cut its price target on the lithium producer's ...
Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.
9d
Zacks Investment Research on MSNCVS Health Takes the Lead in 2025 S&P 500 Chart: Is It a Buy Now?In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...
The best-performing S&P 500 stocks of Q1 2025 include CVS Health, Philip Morris, Newmont, and AT&T, all outperforming amid ...
The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P 500, bagged a ... look at the sector’s performance and where its ...
these were the top 10 performing S&P 500 companies in the first three months of 2025. Ticker: AJG Market capitalization: $88.3 billion Industry: Insurance Q1 performance: 21.6% Ticker: BRO Read next ...
We're nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite recent volatility stemming from tariff talks and other economic ...
Market sentiment remained cautious, with investors also digesting corporate earnings from CVS Health and watching Tesla’s ongoing selloff. At 13:14 GMT, S&P 500 futures edged up 0.08% ...
And concerning the all-star performers, Philip Morris PM, CVS Health CVS, and Newmont NEM all reflect top-performing S&P 500 stocks ... the stock’s strong YTD performance, up nearly 30%.
CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results